MAMA vs STKL

The deterministic health and value scores indicate a severe valuation disconnect; the Piotroski F-Score is 4/9 (Stable), but the Graham Number ($1.81) and Intrinsic Value ($0.84) are drastically lower than the current price of $15.87. While the company exhibits impressive 50% YoY revenue growth and a healthy balance sheet (Debt/Equity 0.32), it is trading at an unsustainable P/E ratio of 132.25. With razor-thin profit margins of 3.08% and a bearish technical trend (10/100), the stock appears to be in a speculative bubble driven by growth expectations rather than fundamental value.

STKL presents a stark contrast between poor fundamental health and strong recent operational momentum. The Piotroski F-Score of 4/9 indicates a stable but fragile financial state, while the current price of $6.47 trades at a massive premium to both the Graham Number ($2.06) and Intrinsic Value ($0.91). While the company shows impressive earnings surprises and revenue growth, the 10-K filing reveals a 'proposed Arrangement' and 'anticipated delisting,' suggesting a corporate action (buyout or privatization) that likely decouples the stock price from traditional valuation metrics.